Cargando…

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis

Chronic airway infection is a key aspect of the pathogenesis of bronchiectasis. A growing interest has been raised on non-tuberculous mycobacteria (NTM) infection. We aimed at describing the clinical characteristics, diagnostic process, therapeutic options and outcomes of bronchiectasis patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faverio, Paola, Stainer, Anna, Bonaiti, Giulia, Zucchetti, Stefano C., Simonetta, Edoardo, Lapadula, Giuseppe, Marruchella, Almerico, Gori, Andrea, Blasi, Francesco, Codecasa, Luigi, Pesci, Alberto, Chalmers, James D., Loebinger, Michael R., Aliberti, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133910/ https://www.ncbi.nlm.nih.gov/pubmed/27854334 http://dx.doi.org/10.3390/ijms17111913

Ejemplares similares

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
por: Stainer, Anna, et al.
Publicado: (2021)

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol
por: Aliberti, Stefano, et al.
Publicado: (2018)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review
por: Gramegna, Andrea, et al.
Publicado: (2022)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria
por: Schweitzer, Michael D., et al.
Publicado: (2017)

Concurrent features of sarcoidosis and hypersensitivity pneumonitis in two patients exposed to fungal antigens
por: Marruchella, Almerico, et al.
Publicado: (2023)

Get together to increase awareness in bronchiectasis: a report of the 2(nd) World Bronchiectasis Conference
por: Aliberti, Stefano, et al.
Publicado: (2018)

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
por: Ronco, Raffaella, et al.
Publicado: (2023)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
por: Faverio, Paola, et al.
Publicado: (2018)

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
por: McDonnell, M J, et al.
Publicado: (2016)

Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017)

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
por: Crichton, Megan L., et al.
Publicado: (2019)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach?
por: Paolini, Valentina, et al.
Publicado: (2018)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Preserved Ratio Impaired Spirometry and Interstitial Lung Abnormalities in Smokers
por: Marruchella, Almerico
Publicado: (2019)

A case-control study on the risk factors associated with the occurrence of non-tuberculous mycobacteria pulmonary disease in bronchiectasis patients
por: Feng, Yinping, et al.
Publicado: (2023)

Influenza A/H1N1 Severe Pneumonia: Novel Morphocytological Findings in Bronchoalveolar Lavage
por: Faverio, Paola, et al.
Publicado: (2014)

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
por: Chalmers, James D., et al.
Publicado: (2017)

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis
por: Contarini, Martina, et al.
Publicado: (2018)

Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights
por: Faverio, Paola, et al.
Publicado: (2019)

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
por: Artaraz, Amaia, et al.
Publicado: (2020)

Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis
por: Zhou, Yunchun, et al.
Publicado: (2022)

Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2016)

Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics
por: Faverio, Paola, et al.
Publicado: (2021)

Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis
por: Chu, Haiqing, et al.
Publicado: (2014)

Methods of phenotypic identification of non-tuberculous mycobacteria
por: Bhalla, Gurpreet S., et al.
Publicado: (2018)

The Incidence of Non-Tuberculous Mycobacteria in Infants in Kenya
por: Kaguthi, Grace, et al.
Publicado: (2019)

Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects
por: Mirsaeidi, Mehdi, et al.
Publicado: (2015)

Patients’ perspectives on bronchiectasis: findings from a social media listening study
por: Delestre-Levai, Irisz, et al.
Publicado: (2021)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?
por: Azzarà, Cecilia, et al.
Publicado: (2023)

Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia
por: Murcia-Aranguren, Martha I, et al.
Publicado: (2001)

The Isoform GC1f of the Vitamin D Binding Protein Is Associated with Bronchiectasis Severity
por: Oriano, Martina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pv02spqkhfk0ct4qpifb9pu7h1